Cassileth BR, Chapman CC. Alternative and com-plementary cancer therapies[J]. Cancer, 1996,77(6): 1026-1034.
Yu JH, Cui Q, Jiang YY, et al. Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF-7[J]. Acta Pharmacol Sin, 2007,28(12):1975-1983.
Wu WY, Guo HZ, Qu GQ, et al. Mechanisms of pseudolaric Acid B-induced apoptosis in bel-7402 cell lines[J]. Am J Chin Med, 2006,34(5):887-899.
Gong XF, Wang MW, Tashiro S, et al. Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2 pathways in human melanoma A375-S2 cells[J]. Arch Pharm Res, 2005,28(1):68-72.
Chen YL, Law PY, Loh HH. Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy[J]. Curr Med Chem Anticancer Agents, 2005, 5(6):575-589.
duPont NC, Monk BJ. Chemotherapy in the management of cervical carcinoma[J]. Clin Adv Hematol Oncol, 2006,4(4):279-286.
Kim D, Kim S, Koh H, et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production[J]. FASEB J, 2001,15(11):1953-1962.
Wu C, Huang J. Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer[J]. J Biol Chem, 2007,282(6):3571-3583.
Ciechomska I, Pyrzynska B, Kazmierczak P, et al. Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells[J]. Oncogene, 2003,22 (48):7617-7627.
沈宏伟,胡红珍,曾海涛,等. 冬凌草甲素作用PI3K/AKT通路诱导HeLa细胞凋亡[J]. 中山大学学报:医学科学版, 2007,28(5):506-510.
Redaelli C, Granucci F, De Gioia L, et al. Synthesis and biological activity of Akt/PI3K inhibitors[J]. Mini Rev Med Chem, 2006,6(10):1127-1136
仁和医学论文网专业提供代写代发医学论文服务,并提供大量论文资料,如有业务需求请咨询网站客服人员!
上一页 [1] [2] [3] [4] [5]